Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | %Female (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113 | Journal of Experimental and Clinical Cancer Research | journal | 0.343 Q3 | 120 | 116 | 266 | 2860 | 278 | 262 | 0.89 | 24.66 | 30.06 | |
112 | Brain Tumor Pathology | journal | 0.347 Q3 | 45 | 20 | 62 | 446 | 52 | 62 | 0.53 | 22.30 | 15.89 | |
111 | Tumor Targeting | journal | 0.384 Q3 | 10 | 0 | 32 | 0 | 35 | 31 | 0.00 | 0.00 | 0.00 | |
110 | Oncology | journal | 0.398 Q3 | 83 | 169 | 833 | 5691 | 891 | 819 | 0.94 | 33.67 | 28.67 | |
109 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.412 Q3 | 65 | 52 | 78 | 1675 | 84 | 65 | 1.08 | 32.21 | 30.00 | |
108 | In Vivo | journal | 0.439 | 72 | 86 | 284 | 3603 | 343 | 282 | 1.23 | 41.90 | 33.13 | |
107 | Hematological Oncology | journal | 0.478 Q3 | 54 | 15 | 41 | 996 | 54 | 41 | 1.17 | 66.40 | 51.35 | |
106 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.491 Q3 | 90 | 146 | 411 | 3088 | 595 | 398 | 1.39 | 21.15 | 22.52 | |
105 | Current Cancer Drug Targets | journal | 0.495 Q3 | 103 | 20 | 16 | 3075 | 24 | 16 | 1.50 | 153.75 | 29.17 | |
104 | Oral Oncology | journal | 0.497 Q3 | 137 | 128 | 520 | 4143 | 606 | 506 | 0.83 | 32.37 | 25.06 | |
103 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.502 Q3 | 108 | 39 | 18 | 5020 | 22 | 18 | 1.22 | 128.72 | 28.16 | |
102 | Pathology and Oncology Research | journal | 0.510 Q3 | 61 | 47 | 147 | 1326 | 176 | 147 | 1.14 | 28.21 | 38.20 | |
101 | Tumor Biology | journal | 0.518 Q3 | 101 | 35 | 146 | 1363 | 211 | 144 | 1.74 | 38.94 | 31.79 | |
100 | Medical Oncology | journal | 0.520 Q3 | 90 | 48 | 139 | 1336 | 237 | 135 | 1.66 | 27.83 | 27.42 | |
99 | BMC Cancer | journal | 0.522 Q3 | 160 | 37 | 20 | 1200 | 30 | 20 | 1.50 | 32.43 | 29.21 | |
98 | Leukemia and Lymphoma | journal | 0.522 Q3 | 102 | 388 | 914 | 12210 | 1399 | 900 | 1.38 | 31.47 | 29.63 | |
97 | Molecular Imaging and Biology | journal | 0.522 Q3 | 78 | 54 | 107 | 1860 | 152 | 107 | 1.40 | 34.44 | 20.40 | |
96 | Oncology Reports | journal | 0.529 Q3 | 115 | 239 | 732 | 5423 | 1042 | 732 | 1.29 | 22.69 | 21.23 | |
95 | Breast Cancer Research | journal | 0.545 Q3 | 175 | 78 | 372 | 1834 | 448 | 330 | 1.48 | 23.51 | 49.74 | |
94 | Cancer Immunity | journal | 0.565 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
93 | Journal of Oral Pathology and Medicine | journal | 0.587 Q3 | 95 | 97 | 261 | 2778 | 490 | 258 | 1.61 | 28.64 | 24.85 | |
92 | Cancer Genetics and Cytogenetics | journal | 0.605 Q3 | 78 | 258 | 788 | 6845 | 1319 | 703 | 1.71 | 26.53 | 41.32 | |
91 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.618 Q3 | 68 | 65 | 182 | 2258 | 312 | 161 | 1.54 | 34.74 | 26.14 | |
90 | Anticancer Research | journal | 0.626 Q3 | 136 | 658 | 2358 | 19065 | 4117 | 2354 | 1.61 | 28.97 | 27.80 | |
89 | Invasion and Metastasis | journal | 0.640 Q2 | 31 | 0 | 11 | 0 | 22 | 11 | 0.00 | 0.00 | 0.00 | |
88 | Cancer Epidemiology | journal | 0.642 Q2 | 86 | 59 | 201 | 2435 | 333 | 199 | 1.47 | 41.27 | 39.15 | |
87 | Breast Cancer Research and Treatment | journal | 0.645 Q2 | 177 | 180 | 902 | 5856 | 1498 | 894 | 1.30 | 32.53 | 38.32 | |
86 | European Journal of Cancer Prevention | journal | 0.661 Q2 | 88 | 98 | 254 | 3087 | 458 | 230 | 1.48 | 31.50 | 31.97 | |
85 | Journal of Neuro-Oncology | journal | 0.666 Q2 | 135 | 147 | 455 | 4911 | 838 | 444 | 1.61 | 33.41 | 25.78 | |
84 | Lung Cancer | journal | 0.667 Q2 | 148 | 251 | 458 | 6323 | 1042 | 434 | 2.16 | 25.19 | 21.10 | |
83 | Cancer Investigation | journal | 0.681 Q2 | 93 | 144 | 301 | 5950 | 547 | 270 | 1.84 | 41.32 | 31.95 | |
82 | Leukemia Research | journal | 0.687 Q2 | 96 | 172 | 449 | 4860 | 842 | 397 | 1.95 | 28.26 | 32.03 | |
81 | Virus Research | journal | 0.699 Q2 | 144 | 162 | 386 | 6189 | 651 | 383 | 1.54 | 38.20 | 32.86 | |
80 | Anti-Cancer Drugs | journal | 0.709 Q2 | 102 | 139 | 379 | 4781 | 818 | 377 | 2.22 | 34.40 | 31.70 | |
79 | Journal of Cancer Research and Clinical Oncology, Supplement | journal | 0.711 Q2 | 13 | 0 | 18 | 0 | 49 | 18 | 2.72 | 0.00 | 0.00 | |
78 | Angiogenesis | journal | 0.717 Q2 | 101 | 29 | 69 | 1523 | 94 | 68 | 0.90 | 52.52 | 33.33 | |
77 | Acta Oncologica, Supplement | journal | 0.747 Q2 | 8 | 0 | 12 | 0 | 31 | 12 | 0.00 | 0.00 | 0.00 | |
76 | International Journal of Biological Markers | journal | 0.751 Q2 | 47 | 46 | 140 | 1021 | 263 | 122 | 1.77 | 22.20 | 45.11 | |
75 | Melanoma Research | journal | 0.769 Q2 | 80 | 86 | 240 | 2464 | 484 | 228 | 1.70 | 28.65 | 34.87 | |
74 | Journal of Cancer Research and Clinical Oncology | journal | 0.773 Q2 | 109 | 106 | 316 | 3050 | 726 | 305 | 2.28 | 28.77 | 30.84 | |
73 | Neuro-Oncology | journal | 0.773 Q2 | 163 | 29 | 89 | 1096 | 187 | 85 | 1.92 | 37.79 | 35.33 | |
72 | Recent Results in Cancer Research | book series | 0.782 Q2 | 63 | 59 | 105 | 702 | 263 | 105 | 2.49 | 11.90 | 26.71 | |
71 | Nuclear Medicine and Biology | journal | 0.808 Q2 | 98 | 106 | 376 | 2912 | 793 | 373 | 2.28 | 27.47 | 27.66 | |
70 | Cancer Chemotherapy and Pharmacology | journal | 0.846 Q2 | 122 | 142 | 503 | 4357 | 1233 | 499 | 2.36 | 30.68 | 30.89 | |
69 | Cancer Letters | journal | 0.848 Q2 | 216 | 371 | 1117 | 11674 | 2677 | 1114 | 2.50 | 31.47 | 28.69 | |
68 | Oncology Research | journal | 0.859 Q2 | 76 | 66 | 250 | 2522 | 641 | 247 | 2.16 | 38.21 | 40.36 | |
67 | International Journal of Hyperthermia | journal | 0.871 Q2 | 98 | 49 | 126 | 2002 | 223 | 122 | 1.88 | 40.86 | 22.90 | |
66 | Sub-Cellular Biochemistry | journal | 0.876 Q2 | 81 | 16 | 71 | 1224 | 130 | 71 | 1.91 | 76.50 | 29.27 | |
65 | Cancer Gene Therapy | journal | 0.883 Q2 | 99 | 125 | 356 | 5286 | 1141 | 354 | 3.04 | 42.29 | 26.85 | |
64 | Cancer Science | journal | 0.950 Q2 | 166 | 180 | 575 | 5717 | 1416 | 567 | 2.19 | 31.76 | 15.07 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®